Skip to main content
OpenTrials
Completed

NCT Number: NCT03692208

Managing Diabetes to Gain Opportunities for a More Active Life

The purpose of this novel patient-facing disease management intervention is to develop and test a system embedded within the electronic medical record to engage patients in personalized goal setting and chronic disease management.

Completed

Looking for future studies?

Notify Me

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Chicago

Chicago, Illinois, 60637, United States

About this study

The purpose of this novel patient-facing disease management intervention, My Diabetes GOAL, is to develop and test a system embedded within the electronic medical record to engage patients in personalized goal setting and chronic disease management by: 1) establishing personalized goals of care based on comorbidities and preferences, 2) tracking diabetes measures against personalized goals, and 3) selecting the route and intensity of care management to help patients achieve their goals (e.g., telephonic care management, in-person care management, and self-care resources). This application can be used to individualize care, increase engagement with patient portals, and improve patient self-efficacy, as they take a more active role in their care.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 65 years and older
  • Diagnosis of Type 2 Diabetes
  • Enrolled in MyChart (University of Chicago Patient Portal)
  • Outpatient clinic visit in the prior year

Exclusion criteria

  • Under 64 years of age
  • No type 2 diabetes
  • Not enrolled in MyChart
  • No outpatient clinic visit in the prior year

Treatment and study plan

My Diabetes Goal Survey and Optional Care Management

Behavioral

The intervention is already described in the intervention arm description.

Primary outcomes

  1. Documentation of Diabetes Goal

    Time frame: Baseline, 6 months

    Documentation of a personalized goal for diabetes care (e.g., A1C target) of diabetes care (yes or no).

Secondary outcomes

  1. Personalized A1C Goals

    Time frame: Baseline, 6 months

    The A1C goal outcome is based on a survey response and is distinct from the measured A1C from laboratory testing. The number of analyzed A1C goal results is therefore dependent on the number of survey respondents.

  2. Patient Ability to Reach Personalized Goals

    Time frame: Baseline, 6 month

    Using EHR data, we will measure whether or not patients are reaching the goals they have documented in the survey.

Other outcomes

  1. Health Care Utilization

    Time frame: 1 year

    We will utilize the EHR to determine the frequency of referrals to telephone care management, the source of referrals (population management, physician), the patient predictors of referrals, and to characterize frequency and content of telephonic management.

Sponsors and collaborators

Lead sponsor

University of Chicago

Other

Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • National Institutes of Health (NIH)

Registry information

Official study title

Managing Diabetes to Gain Opportunities for a More Active Life (My Diabetes GOAL)

Important dates

Study start
2018
Primary completion
2020
Study completion
2020
First posted
Oct 2, 2018
Registry last updated
Feb 21, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.